Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of OBIO will decline by -2.34% over the next 2 Weeks and hit $4.69 by Friday, January 23, 2026. In that time frame, OBIO's share price is expected to range between $4.36 and $5.02.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 23, 2026 | 4.30 | 4.67 | 5.05 |
| Jan 22, 2026 | 4.40 | 4.76 | 5.13 |
| Jan 21, 2026 | 4.42 | 4.79 | 5.13 |
| Jan 20, 2026 | 4.28 | 4.66 | 5.01 |
| Jan 19, 2026 | 4.30 | 4.68 | 5.06 |
| Jan 16, 2026 | 4.37 | 4.73 | 5.10 |
| Jan 15, 2026 | 4.46 | 4.83 | 5.19 |
| Jan 14, 2026 | 4.50 | 4.86 | 5.24 |
| Jan 13, 2026 | 4.38 | 4.72 | 5.06 |
| Jan 12, 2026 | 4.39 | 4.75 | 5.12 |
OBIO shares fell -0.83% in Friday, January 9, 2026's trading session, dropping from a previous close of $4.84 to move at $4.80. The stock demonstrated notable intraday movement (see OBIO's key stats for a full breakdown), fluctuating between $4.71 and $5.00, a +6.05% trading range. While recent weeks have seen some volatility, OBIO has managed to secure a +11.11% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 281.15K shares changing hands, 62.62K more than the previous session. This amounted to $1.35M in total market activity.
Will OBIO Continue Its Upward Trend?
According to analyst ratings and projections for OBIO, Orchestra BioMed Holdings, Inc. shares are anticipated to increase by +4.89%, potentially reaching $5.05 per share by January 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for OBIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the OBIO stock forecast, now is a good time to buy OBIO stock because its current trading price is +2.80% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on OBIO covering social and institutional perspectives.
OBIO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into OBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.74% to 67.11%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 56.35%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.19%, maintains a neutral outlook for the long term. Insights into OBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Orchestra BioMed Short-Term Forecasts
OBIO Forecast For Next 5 Days
Our algorithm anticipates Orchestra BioMed (OBIO) stock could hit $3.36 by Jan 08, 2026. This represents a -30.09% rise from today's price, following a +16.63% change over the past five days.
OBIO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Orchestra BioMed Holdings, Inc. (OBIO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.71, which would mean a -22.71% decrease from the current price of $4.80. Projections for this period range from a high of $4.71 to a low of $2.79.
OBIO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Orchestra BioMed's price over the next three months point to a rise. OBIO stock is expected to peak at $14.28 on Apr 07, 2026 after potentially dipping to $8.07 on Jan 12, 2026. On average, OBIO is likely to trade around $11.71 in the coming 90 days.
Orchestra BioMed Stock Forecast 2025
Based on our predictive models, Orchestra BioMed (OBIO) is expected to trade between $5.92 and $43.95 throughout 2026. This would result in an average price of $14.96, potentially offering investors a +211.67% return from current levels.
Orchestra BioMed Holdings, Inc. Monthly Forecast 2026
January 2026
According to our latest forecast models, Orchestra BioMed Holdings, Inc. (OBIO) is positioned to show a strong performance in January 2026. The price is predicted to move between $7.63 and $11.75, settling at an average of $9.60. This could translate to a +100.00% gain.
February 2026
Based on current market signals, Orchestra BioMed Holdings, Inc. is projected to trend february 2026. We forecast a trading range from $9.46 to $13.06, with a likely average price of $11.00. Investors could expect a potential return of +129.17%.
March 2026
Our predictive algorithms indicate Orchestra BioMed Holdings, Inc. stock may see a shift in March 2026. The expected range spans $10.88–$14.07, with an average target of $12.64. This represents a positive outlook and a possible gain of +163.33%.
April 2026
Analyzing established trends, Orchestra BioMed Holdings, Inc. looks set to move in April 2026. Projections place the stock between $9.93 and $14.28, averaging around $13.17. This suggests a +174.38% gain from current levels.
May 2026
Market indicators suggest Orchestra BioMed Holdings, Inc. could experience notable changes during May 2026. Prices could fluctuate within $10.14 to $17.37, with a midpoint forecast of $14.39. The stock might deliver a +199.79% gain.
June 2026
Forecasting for June 2026, models estimate that Orchestra BioMed Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.06 and $18.30, averaging $15.80. This signals a positive trajectory with potential returns around +229.17%.
July 2026
According to our latest forecast models, Orchestra BioMed Holdings, Inc. (OBIO) is positioned to show a strong performance in July 2026. The price is predicted to move between $10.14 and $22.01, settling at an average of $16.71. This could translate to a +248.13% gain.
August 2026
Based on current market signals, Orchestra BioMed Holdings, Inc. is projected to trend august 2026. We forecast a trading range from $8.19 to $19.15, with a likely average price of $14.27. Investors could expect a potential return of +197.29%.
September 2026
Our predictive algorithms indicate Orchestra BioMed Holdings, Inc. stock may see a shift in September 2026. The expected range spans $7.41–$22.44, with an average target of $14.16. This represents a positive outlook and a possible gain of +195.00%.
October 2026
Analyzing established trends, Orchestra BioMed Holdings, Inc. looks set to move in October 2026. Projections place the stock between $5.92 and $22.90, averaging around $13.84. This suggests a +188.33% gain from current levels.
November 2026
Market indicators suggest Orchestra BioMed Holdings, Inc. could experience notable changes during November 2026. Prices could fluctuate within $7.33 to $32.04, with a midpoint forecast of $17.91. The stock might deliver a +273.12% gain.
December 2026
Forecasting for December 2026, models estimate that Orchestra BioMed Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $10.52 and $43.95, averaging $24.92. This signals a positive trajectory with potential returns around +419.17%.
OBIO's history of dividends and stock splits also plays a role in long-term investor confidence.